Jonathan French Selected Research

anthrax toxin (anthrax lethal factor)

10/2016

Efficacy Projection of Obiltoxaximab for Treatment of Inhalational Anthrax across a Range of Disease Severity.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jonathan French Research Topics

Disease

3	Breast Neoplasms (Breast Cancer) 01/2019 - 12/2017
2	Systemic Lupus Erythematosus (Libman-Sacks Disease) 12/2023 - 01/2023
2	Infections 11/2022 - 12/2015
2	Rheumatoid Arthritis 12/2015 - 06/2010
2	Disease Progression 03/2011 - 01/2010
1	Reinfection 01/2023
1	Malaria 01/2023
1	Pelvic Pain 01/2022
1	Stomach Neoplasms (Stomach Cancer) 01/2022
1	Peritoneal Neoplasms 01/2022
1	Pain (Aches) 01/2022
1	Neoplasms (Cancer) 01/2022
1	Endometriosis 01/2022
1	Giant Cell Tumor of Tendon Sheath 11/2021
1	Body Weight (Weight, Body) 10/2016
1	Toxemia 10/2016
1	Anthrax 10/2016
1	Uterine Hemorrhage (Uterine Bleeding) 03/2003

Drug/Important Bio-Agent (IBA)

3	Ado-Trastuzumab EmtansineIBA 01/2019 - 12/2017
2	Anti-Bacterial Agents (Antibiotics)IBA 11/2022 - 10/2016
2	human ERBB2 proteinIBA 01/2019 - 12/2017
2	tofacitinibIBA 12/2015 - 06/2010
2	Antirheumatic Agents (DMARD)IBA 12/2015 - 06/2010
1	Prostaglandins AIBA 01/2023
1	2- methyl- 3- (4- phenylpiperidino)propionohydroxamic acid hydrochloride (K 76)IBA 01/2023
1	artemisinin (artemisinine)IBA 01/2023
1	Lumefantrine Drug Combination Artemether (Coartem)FDA Link 01/2023
1	Estradiol (Delestrogen)FDA LinkGeneric 01/2022
1	linzagolixIBA 01/2022
1	TransferasesIBA 01/2022
1	avelumabIBA 01/2022
1	LHRH Receptors (Gonadotropin-Releasing Hormone Receptor)IBA 01/2022
1	AlbuminsIBA 01/2022
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2022
1	C-Reactive ProteinIBA 01/2022
1	pexidartinibIBA 11/2021
1	pertuzumabIBA 01/2019
1	ErbB Receptors (EGF Receptor)IBA 12/2017
1	taxaneIBA 12/2017
1	Lapatinib (GW572016)FDA Link 12/2017
1	Capecitabine (Xeloda)FDA Link 12/2017
1	Trastuzumab (Herceptin)FDA Link 12/2017
1	obiltoxaximabIBA 10/2016
1	anthrax toxin (anthrax lethal factor)IBA 10/2016
1	AntitoxinsIBA 10/2016
1	Monoclonal AntibodiesIBA 10/2016
1	Adalimumab (Humira)FDA Link 12/2015
1	Janus Kinase InhibitorsIBA 12/2015
1	Apolipoproteins E (ApoE)IBA 03/2011
1	Janus KinasesIBA 06/2010
1	AcetylcholinesteraseIBA 01/2010

Therapy/Procedure

3	Therapeutics 12/2023 - 12/2017
1	Drug Therapy (Chemotherapy) 01/2022
1	Induction Chemotherapy 01/2022
1	Contraception (Birth Control) 03/2003